Mechanisms Underlying Benign and Reversible Unconjugated Hyperbilirubinemia Observed with Faldaprevir Administration in Hepatitis C Virus Patients

References

Page 1

	Year	Citations
Telaprevir for Retreatment of HCV Infection Stefan Zeuzem, Pietro Andreoné, Stanislas Pol, New England Journal of Medicine	2011	1.5K
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection John G. McHutchison, Eric Lawitz, Mitchell L. Shiffman, New England Journal of Medicine	2009	1.2K
Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver Evita van de Steeg, Viktor Stránecký, Hana Hartmannová, Journal of Clinical Investigation Drug ConjugatesGeneticsHuman Rotor SyndromePathologyMolecular Genetics	2012	379
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver Stephan R. Vavricka, Jessica van Montfoort, Huy Riêm Ha, Hepatology	2002	372
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C Fred Poordad, Eric Lawitz, Kris V. Kowdley, New England Journal of Medicine	2013	285
IN VITRO INHIBITION OF UDP GLUCURONOSYLTRANSFERASES BY ATAZANAVIR AND OTHER HIV PROTEASE INHIBITORS AND THE RELATIONSHIP OF THIS PROPERTY TO IN VIVO BILIRUBIN GLUCURONIDATION Donglu Zhang, Theodore J. Chando, Donald W. Everett, Drug Metabolism and Disposition	2005	283
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options Yoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki, Journal of Hepatology Limited Treatment OptionsViral HepatitisHcv Genotype 1BAntiviral Drug DevelopmentAntiviral Therapy	2012	235
Gilbert Syndrome and the Development of Antiretroviral Therapy–Associated Hyperbilirubinemia Margalida Rotger, Patrick Taffé, Gabriela Bleiber, The Journal of Infectious Diseases	2005	192
Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1 Pieter Annaert, Zhiwei Ye, Bruno Stieger, Xenobiotica	2010	155
Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia Scott Campbell, Sonia M. de Morais, Jinghai J. Xu Chemico-Biological Interactions Medicinal ChemistryNeuropeptidesBiochemistryMedicineNatural Sciences	2004	145

Page 1